Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease

被引:24
作者
Jazaeri, Amir A. [1 ]
机构
[1] Univ Virginia Hlth Syst, W Norman Thornton Div Gynecol Oncol, Dept Obstet & Gynecol, Charlottesville, VA 22908 USA
关键词
BRCA1; BRCA2; Ovarian cancer; Breast cancer; Microarray; Fanconi anemia; GENE-EXPRESSION PROFILES; PROMOTER HYPERMETHYLATION; IMPROVED SURVIVAL; SPORADIC BREAST; BRCA2; MUTATIONS; HELICASE BRIP1; DNA-DAMAGE; CARRIERS; PATHWAY; RISKS;
D O I
10.1016/j.molonc.2009.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BRCA1 and BRCA2 germline mutations account for the majority of hereditary ovarian cancers and comprise 10% of total cases. Ovarian cancers arising from these mutations exhibit both overlapping and distinct clinical and molecular features. The expression profiles of sporadic ovarian cancers show similarities to those of BRCA1 and BRCA2-related tumors suggesting that BRCA-related pathways may be involved in their development as well. The purpose of this review is to consider the available data on ovarian cancers in the context of other investigations of BRCA-related transcriptional alterations, and highlight areas for future research. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 45 条
  • [41] Analysis of PALB2/FANCN-associated breast cancer families
    Tischkowitz, Marc
    Xia, Bing
    Sabbaghian, Nelly
    Reis-Filho, Jorge S.
    Hamel, Nancy
    Li, Guilan
    van Beers, Erik H.
    Li, Lili
    Khalil, Tayma
    Quenneville, Louise A.
    Omeroglu, Atilla
    Poll, Aletta
    Lepage, Pierre
    Wong, Nora
    Nederlof, Petra M.
    Ashworth, Alan
    Tonin, Patricia N.
    Narod, Steven A.
    Livingston, David M.
    Foulkes, William D.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (16) : 6788 - 6793
  • [42] Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers
    Walker, Logan C.
    Waddell, Nic
    Ten Haaf, Anette
    Grimmond, Sean
    Spurdle, Amanda B.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (02) : 229 - 236
  • [43] Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway
    Wang, ZH
    Li, M
    Lu, S
    Zhang, Y
    Wang, HB
    [J]. CANCER BIOLOGY & THERAPY, 2006, 5 (03) : 256 - 260
  • [44] Sporadic epithelial ovarian cancer: Clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway
    Weberpals, Johanne I.
    Clark-Knowles, Katherine V.
    Vanderhyden, Barbara C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) : 3259 - 3267
  • [45] Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
    Xia, Bing
    Sheng, Qing
    Nakanishi, Koji
    Ohashi, Akihiro
    Wu, Jianmin
    Christ, Nicole
    Liu, Xinggang
    Jasin, Maria
    Couch, Fergus J.
    Livingston, David M.
    [J]. MOLECULAR CELL, 2006, 22 (06) : 719 - 729